Shareholders’ proposal ahead of the extraordinary general meeting in Karessa Pharma on 22 October 2019
Shareholders’ representing approximately 49.8% of the shares and votes in the company propose, ahead of the extraordinary general meeting in Karessa Pharma Holding AB (publ) (”Karessa Pharma”) on 22 October 2019 that Kristina Lidén Mascher and Neal Meacham are elected as new board members.Karessa Pharma has, at the request of shareholders representing approximately 49.8% of the shares and votes in the company convened an extraordinary general meeting at 10:00 on 22 October 2019 to consider the election of new board members. Information regarding the board members proposed for new